New York Attorney General Letitia James has secured more than $2.7 billion in total for New York from opioid manufacturers, distributors and marketers.
The collaboration will offer people an opportunity to learn about and potentially participate in a Phase III clinical trial within Walgreens pharmacies.
NACDS submitted the statement before Wednesday’s House Energy and Commerce Subcommittee on Oversight and Investigations and Senate Finance Committee hearings examining the impact of the Change Healthcare cyberattack.
The high-concentration interchangeable biosimilar to AbbVie Biotechnology's Humira manufactured by Alvotech will be distributed under Quallent’s private-label.
